Skip to main content

Animations

MJFF Publications

2821 - 2830 of 6420 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12274
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12243
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12329
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
    Journal Name: Animal Models and Experimental Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ame2.12209
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12684
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12514
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12835
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Dancing Feet Dyskinesia in a Patient with GBA-PD
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20169
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20126
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The silver linings of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00283-1
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.